1. Search Result

Search Result

Results for "811803-05-1" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-13342A
    Apatinib free base

    YN968D1 free base

    VEGFR c-Kit Src RET Autophagy Cancer
    Apatinib free base (YN968D1 free base) is an orally bioavailable tyrosine kinase inhibitor, which selectively targets VEGFR-2 (IC50=1 nM). Apatinib free base (YN968D1 free base) is an anti-angiogenic drug for the treatment of advanced or metastatic gastric cancer. Apatinib free base (YN968D1 free base) potently inhibits Ret, c-Kit and c-Src with IC50s of 13, 429 and 530 nM, respectively. It also inhibits cellular phosphorylation of VEGFR-2, c-kit and PDGFRβ.